Coeptis Therapeutics Holdings Overview
Valuation check: COEP's P/E ratio is -2.17, below the sector sector average of 33.83.
Get informed when a big investor buys or sells
+ Follow-2.17
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Coeptis Therapeutics Holdings (COEP) currently reports a P/E ratio of -2.17. That is below the sector sector average of 33.83. Use the charts on this page to explore Coeptis Therapeutics Holdings's P/E ratio history and peer comparisons.
Coeptis Therapeutics Holdings's P/E ratio of -2.17 is lower than the its sector sector average of 33.83. That is roughly 106.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Coeptis Therapeutics Holdings's market price to a fundamental measure such as earnings, sales, or book value. At -2.17, COEP can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -2.17, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 33.83. From there, open related valuation or income-statement pages for Coeptis Therapeutics Holdings, and consider following COEP for alerts when major investors trade the stock.
